1. Home
  2. FUN vs PHVS Comparison

FUN vs PHVS Comparison

Compare FUN & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cedar Fair L.P.

FUN

Cedar Fair L.P.

HOLD

Current Price

$19.98

Market Cap

1.7B

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$26.80

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUN
PHVS
Founded
1983
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
FUN
PHVS
Price
$19.98
$26.80
Analyst Decision
Buy
Buy
Analyst Count
12
11
Target Price
$23.92
$41.82
AVG Volume (30 Days)
1.6M
186.6K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,100,289,000.00
N/A
Revenue This Year
$4.76
N/A
Revenue Next Year
$3.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.45
N/A
52 Week Low
$12.51
$12.01
52 Week High
$38.27
$29.85

Technical Indicators

Market Signals
Indicator
FUN
PHVS
Relative Strength Index (RSI) 65.79 45.76
Support Level $14.85 $24.55
Resistance Level $27.37 $28.72
Average True Range (ATR) 0.96 1.38
MACD 0.29 -0.03
Stochastic Oscillator 92.44 32.65

Price Performance

Historical Comparison
FUN
PHVS

About FUN Cedar Fair L.P.

Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS. The parks are family-oriented, with recreational facilities for people of all ages, and provide clean and attractive environments with exciting rides and immersive entertainment. The Company generates revenue from sales of admission to the amusement parks and water parks, from purchases of food, merchandise and games both inside and outside the parks, from the sale of accommodations and other extra-charge.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: